Intro to Drug Discovery Flashcards

1
Q

What is a drug?

A

A substance that has a physiological effect when introduced to the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what can a drug be used for?

A

Diagnosis, treatment, prevention of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Can drugs vary in sizes?

A

YES- some drugs have Mr as small as 7- lithium all the way to 150000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is dimorphic different to morphine?

A

has acetyl groups- allows better brain penetration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is dimorphine metabolised to in the body?

A

Morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Des codeine have a similar structure to morphine?

A

YES- smaller

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Is naltrexone similar to morphine chemically?

A

YES- increased in size of methyl group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which overdose can Naltrexone treat and how?

A

opioid OD

  • works as an antagonist for the receptor opioids bind to as agonists
  • competitive inhibition–> opioids cant bind
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is Naloxegol similar to Morphine and what does it do?

A

YES

prevents constipation in patients with opioid use- reduces absorption in the GIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is loperamide and what does it do?

A
  • Immodium
  • Extremely potent opioid agonist
  • treats diarrhoea- has very little systemic exposure so mostly absorbed in GIT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drug discovery can be split into 2 parts?

A
  1. drug discovery- finding a compound suitable for clinical trials
  2. drug dev- testing this agent for use in clinic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 8 steps in drug development?

A
  1. target ID
  2. hit ID
  3. lead ID
  4. Lead optimisation
  5. pre-clinical dev
  6. clinical dev 1,2,3
  7. launch
  8. post launch- pharmacovigilance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What must the drug demonstrate tone progressed into clinical trials?

A
  1. desired biological effect
  2. suitable pharmacokinetics e.g. solubility, permeability
  3. likely to be well tolerated by patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do severe toxicological effects do to the drug process?

A

stop the whole project

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is NOAELs?

A

No Observable Adverse Effects Limits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do phase 1 of clinical dev involve?

A

phase 1- demonstration of exposure + assessment of safety

17
Q

What does phase 2 of clinical dev involve?

A

2a- proof of principle- does the drug alter the target

2b- prof of concept- does drug have impact on disease progression

18
Q

what does phase 3 of drug dev involve?

A

demonstration of efficacy & safety

19
Q

What % of compounds are likely to be approved for clinical use?

A

10%

20
Q

What is multi- parameter optimisation?

A
  1. dissolution
  2. absorption
  3. interactions with target proteins
  4. interactions with other proteins
  5. metabolism
  6. distribution
  7. excretion
21
Q

What is DMTA cycle?

A

Design compound
Make compound
Test compound
Analyse compound

22
Q

what is a Hit compound?

A

a compound with biological activity in a bias model

23
Q

what is a Lead compound?

A

a comp with biological activity in in vitro models

24
Q

What is a Candidate drug?

A

a comp with an overall profile consistent with the target product profile